Literature DB >> 28087423

Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction?

Tamara Stampalija1, Birgit Arabin2, Hans Wolf3, Caterina M Bilardo4, Christoph Lees5.   

Abstract

BACKGROUND: Reduced fetal middle cerebral artery Doppler impedance is associated with hypoxemia in fetal growth restriction. It remains unclear as to whether this finding could be useful in timing delivery, especially in the third trimester. In this regard there is a paucity of evidence from prospective studies.
OBJECTIVES: The aim of this study was to determine whether there is an association between middle cerebral artery Doppler impedance and its ratio with the umbilical artery in relation to neonatal and 2 year infant outcome in early fetal growth restriction (26+0-31+6 weeks of gestation). Additionally we sought to explore which ratio is more informative for clinical use. STUDY
DESIGN: This is a secondary analysis from the Trial of Randomized Umbilical and Fetal Flow in Europe, a prospective, multicenter, randomized management study on different antenatal monitoring strategies (ductus venosus Doppler changes and computerized cardiotocography short-term variation) in fetal growth restriction diagnosed between 26+0 and 31+6 weeks. We analyzed women with middle cerebral artery Doppler measurement at study entry and within 1 week before delivery and with complete postnatal follow-up (374 of 503). The primary outcome was survival without neurodevelopmental impairment at 2 years corrected for prematurity. Neonatal outcome was defined as survival until first discharge home without severe neonatal morbidity. Z-scores were calculated for middle cerebral artery pulsatility index and both umbilicocerebral and cerebroplacental ratios. Odds ratios of Doppler parameter Z-scores for neonatal and 2 year infant outcome were calculated by multivariable logistic regression analysis adjusted for gestational age and birthweight p50 ratio.
RESULTS: Higher middle cerebral artery pulsatility index at inclusion but not within 1 week before delivery was associated with neonatal survival without severe morbidity (odds ratio, 1.24; 95% confidence interval, 1.02-1.52). Middle cerebral artery pulsatility index Z-score and umbilicocerebral ratio Z-score at inclusion were associated with 2 year survival with normal neurodevelopmental outcome (odds ratio, 1.33; 95% confidence interval, 1.03-1.72, and odds ratio, 0.88; 95% confidence interval, 0.78-0.99, respectively) as were gestation at delivery and birthweight p50 ratio (odds ratio, 1.41; 95% confidence interval, 1.20-1.66, and odds ratio, 1.86; 95% confidence interval, 1.33-2.60, respectively). When comparing cerebroplacental ratio against umbilicocerebral ratio, the incremental range of the cerebroplacental ratio tended toward zero, whereas the umbilicocerebral ratio tended toward infinity as the values became more abnormal.
CONCLUSION: In a monitoring protocol based on ductus venosus and cardiotocography in early fetal growth restriction (26+0-31+6 weeks of gestation), the impact of middle cerebral artery Doppler and its ratios on outcome is modest and less marked than birthweight and delivery gestation. It is unlikely that middle cerebral artery Doppler and its ratios are informative in optimizing the timing of delivery in fetal growth restriction before 32 weeks of gestation. The umbilicocerebral ratio allows for a better differentiation in the abnormal range than the cerebroplacental ratio.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Doppler velocimetry; cerebroplacental ratio; intrauterine growth restriction; middle cerebral artery; neonatal; umbilicocerebral ratio

Mesh:

Year:  2017        PMID: 28087423     DOI: 10.1016/j.ajog.2017.01.001

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.

Authors:  Christoph C Lees; Roberto Romero; Tamara Stampalija; Andrea Dall'Asta; Greggory A DeVore; Federico Prefumo; Tiziana Frusca; Gerard H A Visser; John C Hobbins; Ahmet A Baschat; Caterina M Bilardo; Henry L Galan; Stuart Campbell; Dev Maulik; Francesc Figueras; Wesley Lee; Julia Unterscheider; Herbert Valensise; Fabricio Da Silva Costa; Laurent J Salomon; Liona C Poon; Enrico Ferrazzi; Giancarlo Mari; Giuseppe Rizzo; John C Kingdom; Torvid Kiserud; Kurt Hecher
Journal:  Am J Obstet Gynecol       Date:  2022-01-10       Impact factor: 10.693

2.  Fetal Brain-Sparing, Postnatal Cerebral Oxygenation, and Neurodevelopment at 4 Years of Age Following Fetal Growth Restriction.

Authors:  Anne E Richter; Sahar Salavati; Elisabeth M W Kooi; Anne E den Heijer; Anne B Foreman; Mirthe H Schoots; Caterina M Bilardo; Sicco A Scherjon; Jozien C Tanis; Arend F Bos
Journal:  Front Pediatr       Date:  2020-05-06       Impact factor: 3.418

Review 3.  Role of umbilicocerebral and cerebroplacental ratios in prediction of perinatal outcome in FGR pregnancies.

Authors:  H Coenen; J Braun; H Köster; M Möllers; R Schmitz; J Steinhard; K Oelmeier
Journal:  Arch Gynecol Obstet       Date:  2021-10-02       Impact factor: 2.493

4.  Neurodevelopment Outcome in Children with Fetal Growth Restriction at Six Years of Age: A Retrospective Cohort Study.

Authors:  María José Benítez Marín; Juan Antonio Blanco Elena; Jesús Marín Clavijo; Jesús Jiménez López; Daniel María Lubián López; Ernesto González Mesa
Journal:  Int J Environ Res Public Health       Date:  2022-09-03       Impact factor: 4.614

5.  Fetal cerebral blood-flow redistribution: analysis of Doppler reference charts and association of different thresholds with adverse perinatal outcome.

Authors:  H Wolf; T Stampalija; C C Lees
Journal:  Ultrasound Obstet Gynecol       Date:  2021-11       Impact factor: 7.299

6.  Fetal-placental blood flow and neurodevelopment in childhood: population-based neuroimaging study.

Authors:  S Sammallahti; H Tiemeier; S Louwen; E Steegers; M Hillegers; V W V Jaddoe; T White
Journal:  Ultrasound Obstet Gynecol       Date:  2021-08       Impact factor: 7.299

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.